The forecasted mortality rate for malignant neoplasms among females in the UK shows a steady increase from 79.41 thousand in 2024 to 80.29 thousand in 2028. This trend indicates a year-on-year growth of approximately 0.27%. In 2023, this figure was around 79.20 thousand, marking a continual rise since then. Over the five-year forecast period, the Compound Annual Growth Rate (CAGR) is approximately 0.28%, reflecting a modest escalation in mortality rates.
Looking forward, factors such as advancements in early detection and treatment, changes in lifestyle factors, and potential healthcare policy shifts are crucial to monitor. These could significantly influence the trajectory of mortality rates associated with malignant neoplasms.
